Evaluation of oxidative stress levels in obesity and diabetes by the free oxygen radical test and free oxygen radical defence assays and correlations with anthropometric and laboratory parameters

Table 2 Demographic, clinical and biochemical parameters of obese type 2 diabetes mellitus subjects vs obese non-diabetic patients

	T2DM	Obese non-diabetic subjects	P value
Male/Female (n)	6/27	15/54	0.7965
Age (yr)	66.45 (9.78)	60.07 (9.79)	0.0027
BMI (kg/m2)	36.66 (4.01)	35.32 (3.57)	0.0920
WC (cm)	107.24 (13.91)	106.26 (13.04)	0.7286
FPG (mg/dL)	153.32 (56.94)	100.45 (13.91)	< 0.0001
TC (mg/dL)	231.92 (46.75)	227.11 (44.74)	0.6180
HDL-c (mg/dL)	43.98 (10.48)	49.51 (13.30)	0.0384
LDL-c (mg/dL)	137.54 (38.10)	143.80 (44.47)	0.4885
TG (mg/dL)	149.41 (111.44)	160.60 (82.18)	0.5690
UA (mg/dL)	4.70 (1.33)	4.32 (1.10)	0.1319
FORT (mmol/L H2O2)	3.16 (0.39)	2.99 (0.33)	0.0233
FORD (mmol/L Trolox)	0.67 (0.15)	0.72 (0.14)	0.0649

Data are presented as mean ± SD or as n. T2DM: Type 2 diabetes mellitus; BMI: Body mass index; WC: Waist circumference; FGP: Fasting plasma glucose; TC: Total cholesterol; HDL-c: High-density lipoprotein cholesterol; LDL-c: Low-density lipoprotein cholesterol; TG: Triglycerides; UA: Uric acid; eGFR: Estimated glomerular filtration rate; FORT: Free oxygen radical test; FORD: Free oxygen radical defence.